Loading chat...
CA AB425
Bill
Status
Passed
10/7/2023
Primary Sponsor
David Alvarez
Click for details
AI Summary
- Adds pharmacogenomic testing as a covered benefit under Medi-Cal beginning July 1, 2024
- Defines pharmacogenomic testing as laboratory genetic testing (including panel tests) to identify how a person's genetics impact medication efficacy, toxicity, and safety
- Implementation is conditioned on receipt of necessary federal approvals and availability of federal financial participation
- Department may implement the provision through all-county letters or similar instructions without formal regulatory action
- Legislature intends to improve medication safety and efficacy, reduce adverse drug events, and address California's opioid crisis through this coverage
Legislative Description
Medi-Cal: pharmacogenomic testing.
Last Action
Chaptered by Secretary of State - Chapter 329, Statutes of 2023.
10/7/2023
Committee Referrals
Appropriations6/29/2023
Health6/14/2023
Rules6/1/2023
Appropriations3/29/2023
Health2/17/2023
Full Bill Text
No bill text available